Search
Biotechnology
From global DNA screening standards to safeguards for benchtop synthesizers and AI tools, a new biosecurity playbook is taking shape.
By treating the human body as an information system, scientists are using AI to simulate cells, visualize hidden biology, and detect disease at its earliest — and most preventable — stages.
Biohub
From treating specific diseases to targeting aging itself, Progress Conference 2025 explored the many routes to extending life.
For many of us, our imperfect vision compels us to wear corrective lenses to see properly. Here's what everyone should know about LASIK.
By inviting players to tackle real scientific problems, games can offer a hand in solving medicine’s toughest challenges.
Welcome to The Nightcrawler — a weekly newsletter from Eric Markowitz covering tech, innovation, and long-term thinking.
Hawking’s refusal to upgrade his communication system preserved a voice that became iconic, not just for its sound, but for the profound identity it conveyed.
“Neurotech is not just about the brain,” says Synchron CTO Riki Banerjee, explaining how their tech can help with paralysis, brain diseases, and beyond.
For a substantial part of human history, people thought smoking tobacco was perfectly healthy. Native American tribes, who introduced the tobacco plant to Europeans and — by extension, the rest […]
Of the millions of substances people encounter daily, health researchers have focused on only a few hundred. Those in the emerging field of exposomics want to change that.
Benjamin Oakes — CEO of buzz-worthy biotech company Scribe Therapeutics — joins Big Think for a chat about innovation, human endeavor, and more.
As creatures and machines meld together in increasingly advanced forms, ethicists are starting to take note.
Kurzweil predicts that AI will combine with biotechnology to defeat degenerative diseases this decade. Then things will get really interesting.
The sober reality behind the effectiveness of two new drugs touted as Alzheimer's breakthroughs: lecanemab and donanemab.